Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasonex OSA
NCT01671852Phase 3Withdrawn
- Sponsor
- Children's & Women's Health Centre of British Columbia
- Start
- May 2012
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mometasone furoate nasal spray in obstructive sleep apnea (OSA), sponsored by Children's & Women's Health Centre of British Columbia. Planned start May 2012; status: withdrawn.
02
Drugs
mometasone furoate nasal spray
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT01671852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01671852.